Publication | Closed Access
Efficacy and Safety of Tocilizumab for the Treatment of Systemic Sclerosis: Results from a Phase 3 Randomized Controlled Trial
33
Citations
0
References
2018
Year
Autoimmune DiseaseSystemic SclerodermaSystemic TreatmentImmunologyClinical TrialsSystemic SclerosisMultiple SclerosisMedicinePhase 3
No additional data available for this publication yet. Check back later!